FHL1, a LIM-domain protein, and PITX2, a homeobox transcription factor, both function as tumor suppressors or oncogenes depending on the cellular context and are involved in regulating major signaling cascades such as MAPK, TGF-β, and WNT/β-catenin pathways (56, 57). The gene discussed is PITX2; the disease is neoplasm.